Scholar Rock Holding Corp (SRRK)
12.48
-1.84
(-12.85%)
USD |
NASDAQ |
May 17, 16:00
11.85
-0.63
(-5.05%)
After-Hours: 20:00
Scholar Rock SG&A Expense (Quarterly): 15.32M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.32M |
| December 31, 2023 | 13.07M |
| September 30, 2023 | 13.34M |
| June 30, 2023 | 12.22M |
| March 31, 2023 | 10.77M |
| December 31, 2022 | 10.82M |
| September 30, 2022 | 10.47M |
| June 30, 2022 | 11.07M |
| March 31, 2022 | 10.76M |
| December 31, 2021 | 10.36M |
| September 30, 2021 | 11.28M |
| June 30, 2021 | 9.265M |
| March 31, 2021 | 9.366M |
| December 31, 2020 | 7.76M |
| September 30, 2020 | 8.272M |
| Date | Value |
|---|---|
| June 30, 2020 | 6.365M |
| March 31, 2020 | 5.822M |
| December 31, 2019 | 5.856M |
| September 30, 2019 | 6.181M |
| June 30, 2019 | 4.71M |
| March 31, 2019 | 4.07M |
| December 31, 2018 | 5.435M |
| September 30, 2018 | 3.173M |
| June 30, 2018 | 3.46M |
| March 31, 2018 | 2.315M |
| December 31, 2017 | 1.571M |
| September 30, 2017 | 1.164M |
| June 30, 2017 | 1.177M |
| March 31, 2017 | 1.173M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
4.71M
Minimum
Jun 2019
15.32M
Maximum
Mar 2024
9.654M
Average
10.42M
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen Inc | 1.808B |
| Eli Lilly and Co | 1.836B |
| Ocular Therapeutix Inc | 24.33M |
| Alpine Immune Sciences Inc | 7.271M |
| X4 Pharmaceuticals Inc | 17.44M |